Does LEUPROLIDE Cause Prostatic specific antigen increased? 2,432 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,432 reports of Prostatic specific antigen increased have been filed in association with LEUPROLIDE (Fensolvi). This represents 3.4% of all adverse event reports for LEUPROLIDE.
2,432
Reports of Prostatic specific antigen increased with LEUPROLIDE
3.4%
of all LEUPROLIDE reports
225
Deaths
297
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From LEUPROLIDE?
Of the 2,432 reports, 225 (9.3%) resulted in death, 297 (12.2%) required hospitalization, and 12 (0.5%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 2,432 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Asthenia (2,176)
Off label use (2,060)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
OLAPARIB (176)
Which LEUPROLIDE Alternatives Have Lower Prostatic specific antigen increased Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM